Goldman Sachs reiterates Neutral on Ermenegildo Zegna stock, $14 target

Goldman Sachs reiterated its Neutral rating on Ermenegildo Zegna Group with a $14.00 price target, about 12% above the cited $12.52 share price. The company’s first-half 2026 revenue was $517.12 million, 7.06% above the $483 million forecast, supported by stronger direct-to-consumer sales and brand mix; reported profit declined, while adjusted EBIT rose to EUR 74 million from EUR 69 million a year earlier. The results present a mixed picture of sales growth and profit pressure.

Analysis

The investable question is whether sales growth converts into operating profit—not whether the revenue beat looks strong in isolation. A richer direct-to-consumer mix can improve control over pricing and customer data, but it may also bring higher store, staffing, and inventory costs; the reported-profit decline makes that conversion the key verification point. Adjusted EBIT growth is encouraging, but does not by itself resolve the divergence between adjusted and reported results.

Near term, the reiterated Neutral stance and limited implied upside in the cited target argue against treating the sales beat as a fresh catalyst. Over the next 1–3 months, watch guidance and the next earnings update for evidence that DTC growth is lifting operating leverage rather than just shifting channel mix. Over 6–18 months, sustained full-price sell-through would support brand investment and pricing power; weaker luxury demand could instead expose fixed retail costs and inventory risk. Brunello Cucinelli, Moncler, and LVMH are useful read-throughs for luxury demand, but not direct substitutes for Zegna’s brand mix.

Contrarian angle: the market may underweight the strategic value of owned-channel growth, yet overestimate its near-term earnings benefit. A routine analyst reiteration is not evidence of a changed fundamental outlook. No high-conviction directional trade is warranted without margin and inventory detail.

Key Decisions for Investors

• Do not chase the revenue beat on its own; keep ZGN on a watchlist pending the next update on reported-profit conversion, gross/operating margins, and DTC performance.
• If considering exposure, prefer a staged entry after evidence that DTC growth is not being bought with materially higher operating costs or inventory. The thesis is weakened by further reported-profit deterioration or guidance that fails to convert sales growth into earnings.
• Monitor luxury peer results and demand indicators for confirmation or reversal: broad-based weakness would challenge the growth thesis, while Zegna-specific margin improvement alongside resilient sell-through would support reassessment.
• Before taking a relative-value position against luxury peers, verify comparable valuation, brand exposure, currency effects, and channel mix; the supplied data are insufficient to establish a clean pair trade.